{
  "disease_name": "Paroxysmal nocturnal hemoglobinuria",
  "orpha_code": "447",
  "drugs": [
    {
      "name": "FABHALTA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/676579?name=447&mode=orpha&region=",
      "regulatory_id": "676579",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "FABHALTA(Tradename                        - 17/05/2024)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "FABHALTA(Tradename                        - 17/05/2024)",
        "(Tradename                        - 17/05/2024)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/660409?name=447&mode=orpha&region=&status=all",
          "text": "FABHALTA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/676579?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "VOYDEYA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/673826?name=447&mode=orpha&region=",
      "regulatory_id": "673826",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "VOYDEYA(Tradename                        - 19/04/2024)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "VOYDEYA(Tradename                        - 19/04/2024)",
        "(Tradename                        - 19/04/2024)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/665114?name=447&mode=orpha&region=&status=all",
          "text": "VOYDEYA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/673826?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "ASPAVELI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/624357?name=447&mode=orpha&region=",
      "regulatory_id": "624357",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "ASPAVELI(Tradename                        - 13/12/2021)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "ASPAVELI(Tradename                        - 13/12/2021)",
        "(Tradename                        - 13/12/2021)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/624355?name=447&mode=orpha&region=&status=all",
          "text": "ASPAVELI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/624357?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PIASKY",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/687035?name=447&mode=orpha&region=",
      "regulatory_id": "687035",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "PIASKY(Tradename                        - 22/08/2024)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "PIASKY(Tradename                        - 22/08/2024)",
        "(Tradename                        - 22/08/2024)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/684344?name=447&mode=orpha&region=&status=all",
          "text": "PIASKY",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687035?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "EPYSQLI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/650347?name=447&mode=orpha&region=",
      "regulatory_id": "650347",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "EPYSQLI(Tradename                        - 26/05/2023)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "EPYSQLI(Tradename                        - 26/05/2023)",
        "(Tradename                        - 26/05/2023)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/650346?name=447&mode=orpha&region=&status=all",
          "text": "EPYSQLI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/650347?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "ULTOMIRIS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/557038?name=447&mode=orpha&region=",
      "regulatory_id": "557038",
      "orpha_substance_code": "ORPHA:71211",
      "details": [
        "ULTOMIRIS(Tradename                        - 05/05/2023)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuriaORPHA:71211 Neuromyelitis optica spectrum disorder",
        "ULTOMIRIS(Tradename                        - 05/05/2023)",
        "(Tradename                        - 05/05/2023)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuriaORPHA:71211 Neuromyelitis optica spectrum disorder",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/557036?name=447&mode=orpha&region=&status=all",
          "text": "ULTOMIRIS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/71211",
          "text": "ORPHA:71211 Neuromyelitis optica spectrum disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/557038?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "BEKEMV",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/650353?name=447&mode=orpha&region=",
      "regulatory_id": "650353",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "BEKEMV(Tradename                        - 19/04/2023)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "BEKEMV(Tradename                        - 19/04/2023)",
        "(Tradename                        - 19/04/2023)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/650352?name=447&mode=orpha&region=&status=all",
          "text": "BEKEMV",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/650353?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "SOLIRIS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/563093?name=447&mode=orpha&region=",
      "regulatory_id": "563093",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "SOLIRIS(Tradename                        - 20/06/2007)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "SOLIRIS(Tradename                        - 20/06/2007)",
        "(Tradename                        - 20/06/2007)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/82335?name=447&mode=orpha&region=&status=all",
          "text": "SOLIRIS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/563093?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Iptacopan",
      "substance_url": "/en/drug/substance/536870?name=447&mode=orpha&region=&status=all",
      "substance_id": "536870",
      "regulatory_url": "/en/drug/regulatory/589275?name=447&mode=orpha&region=",
      "regulatory_id": "589275",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Iptacopan(Medicinal product                        - 04/06/2020)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Iptacopan(Medicinal product                        - 04/06/2020)",
        "(Medicinal product                        - 04/06/2020)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/536870?name=447&mode=orpha&region=&status=all",
          "text": "Iptacopan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589275?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Danicopan",
      "substance_url": "/en/drug/substance/500656?name=447&mode=orpha&region=&status=all",
      "substance_id": "500656",
      "regulatory_url": "/en/drug/regulatory/500657?name=447&mode=orpha&region=",
      "regulatory_id": "500657",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Danicopan(Medicinal product                        - 12/12/2017)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Danicopan(Medicinal product                        - 12/12/2017)",
        "(Medicinal product                        - 12/12/2017)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/500656?name=447&mode=orpha&region=&status=all",
          "text": "Danicopan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/500657?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PEGylated peptide inhibitor of complement C3",
      "substance_url": "/en/drug/substance/489701?name=447&mode=orpha&region=&status=all",
      "substance_id": "489701",
      "regulatory_url": "/en/drug/regulatory/489702?name=447&mode=orpha&region=",
      "regulatory_id": "489702",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "PEGylated peptide inhibitor of complement C3(Medicinal product                        - 22/05/2017)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "PEGylated peptide inhibitor of complement C3(Medicinal product                        - 22/05/2017)",
        "(Medicinal product                        - 22/05/2017)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/489701?name=447&mode=orpha&region=&status=all",
          "text": "PEGylated peptide inhibitor of complement C3",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/489702?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Coversin",
      "substance_url": "/en/drug/substance/480224?name=447&mode=orpha&region=&status=all",
      "substance_id": "480224",
      "regulatory_url": "/en/drug/regulatory/480229?name=447&mode=orpha&region=",
      "regulatory_id": "480229",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Coversin(Medicinal product                        - 29/08/2016)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Coversin(Medicinal product                        - 29/08/2016)",
        "(Medicinal product                        - 29/08/2016)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480224?name=447&mode=orpha&region=&status=all",
          "text": "Coversin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480229?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)",
      "substance_url": "/en/drug/substance/406538?name=447&mode=orpha&region=&status=all",
      "substance_id": "406538",
      "regulatory_url": "/en/drug/regulatory/412201?name=447&mode=orpha&region=",
      "regulatory_id": "412201",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)(Medicinal product                        - 22/08/2014)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)(Medicinal product                        - 22/08/2014)",
        "(Medicinal product                        - 22/08/2014)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/406538?name=447&mode=orpha&region=&status=all",
          "text": "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/412201?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide",
      "substance_url": "/en/drug/substance/627324?name=447&mode=orpha&region=&status=all",
      "substance_id": "627324",
      "regulatory_url": "/en/drug/regulatory/627326?name=447&mode=orpha&region=",
      "regulatory_id": "627326",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide(Medicinal product                        - 19/02/2021)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide(Medicinal product                        - 19/02/2021)",
        "(Medicinal product                        - 19/02/2021)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627324?name=447&mode=orpha&region=&status=all",
          "text": "(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627326?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker",
      "substance_url": "/en/drug/substance/484834?name=447&mode=orpha&region=&status=all",
      "substance_id": "484834",
      "regulatory_url": "/en/drug/regulatory/484838?name=447&mode=orpha&region=",
      "regulatory_id": "484838",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker(Medicinal product                        - 14/10/2016)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker(Medicinal product                        - 14/10/2016)",
        "(Medicinal product                        - 14/10/2016)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/484834?name=447&mode=orpha&region=&status=all",
          "text": "15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/484838?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Ravulizumab",
      "substance_url": "/en/drug/substance/479982?name=447&mode=orpha&region=&status=all",
      "substance_id": "479982",
      "regulatory_url": "/en/drug/regulatory/479983?name=447&mode=orpha&region=",
      "regulatory_id": "479983",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Ravulizumab(Medicinal product                        - 30/05/2016)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Ravulizumab(Medicinal product                        - 30/05/2016)",
        "(Medicinal product                        - 30/05/2016)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/479982?name=447&mode=orpha&region=&status=all",
          "text": "Ravulizumab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/479983?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Eculizumab",
      "substance_url": "/en/drug/substance/82334?name=447&mode=orpha&region=&status=all",
      "substance_id": "82334",
      "regulatory_url": "/en/drug/regulatory/133846?name=447&mode=orpha&region=",
      "regulatory_id": "133846",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Eculizumab(Medicinal product                        - 17/10/2003)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Eculizumab(Medicinal product                        - 17/10/2003)",
        "(Medicinal product                        - 17/10/2003)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/82334?name=447&mode=orpha&region=&status=all",
          "text": "Eculizumab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133846?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Myristoylated-peptidyl-recombinant Human CD59",
      "substance_url": "/en/drug/substance/82336?name=447&mode=orpha&region=&status=all",
      "substance_id": "82336",
      "regulatory_url": "/en/drug/regulatory/133795?name=447&mode=orpha&region=",
      "regulatory_id": "133795",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Myristoylated-peptidyl-recombinant Human CD59(Medicinal product                        - 11/09/2002)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Myristoylated-peptidyl-recombinant Human CD59(Medicinal product                        - 11/09/2002)",
        "(Medicinal product                        - 11/09/2002)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/82336?name=447&mode=orpha&region=&status=all",
          "text": "Myristoylated-peptidyl-recombinant Human CD59",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133795?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PIASKY",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/684345?name=447&mode=orpha&region=",
      "regulatory_id": "684345",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "PIASKY(Tradename                        - 20/06/2024)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "PIASKY(Tradename                        - 20/06/2024)",
        "(Tradename                        - 20/06/2024)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/684344?name=447&mode=orpha&region=&status=all",
          "text": "PIASKY",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/684345?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "VOYDEYA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/665126?name=447&mode=orpha&region=",
      "regulatory_id": "665126",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "VOYDEYA(Tradename                        - 29/03/2024)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "VOYDEYA(Tradename                        - 29/03/2024)",
        "(Tradename                        - 29/03/2024)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/665114?name=447&mode=orpha&region=&status=all",
          "text": "VOYDEYA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/665126?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "FABHALTA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/660482?name=447&mode=orpha&region=",
      "regulatory_id": "660482",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "FABHALTA(Tradename                        - 05/12/2023)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "FABHALTA(Tradename                        - 05/12/2023)",
        "(Tradename                        - 05/12/2023)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/660409?name=447&mode=orpha&region=&status=all",
          "text": "FABHALTA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/660482?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "ULTOMIRIS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/623286?name=447&mode=orpha&region=",
      "regulatory_id": "623286",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "ULTOMIRIS(Tradename                        - 07/06/2021)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "ULTOMIRIS(Tradename                        - 07/06/2021)",
        "(Tradename                        - 07/06/2021)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/557036?name=447&mode=orpha&region=&status=all",
          "text": "ULTOMIRIS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/623286?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Empaveli",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/623243?name=447&mode=orpha&region=",
      "regulatory_id": "623243",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Empaveli(Tradename                        - 14/05/2021)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Empaveli(Tradename                        - 14/05/2021)",
        "(Tradename                        - 14/05/2021)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/616471?name=447&mode=orpha&region=&status=all",
          "text": "Empaveli",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/623243?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "ULTOMIRIS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/623284?name=447&mode=orpha&region=",
      "regulatory_id": "623284",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "ULTOMIRIS(Tradename                        - 09/10/2020)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "ULTOMIRIS(Tradename                        - 09/10/2020)",
        "(Tradename                        - 09/10/2020)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/557036?name=447&mode=orpha&region=&status=all",
          "text": "ULTOMIRIS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/623284?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "ULTOMIRIS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/543097?name=447&mode=orpha&region=",
      "regulatory_id": "543097",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "ULTOMIRIS(Tradename                        - 21/12/2018)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "ULTOMIRIS(Tradename                        - 21/12/2018)",
        "(Tradename                        - 21/12/2018)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/557036?name=447&mode=orpha&region=&status=all",
          "text": "ULTOMIRIS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/543097?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "SOLIRIS",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131171?name=447&mode=orpha&region=",
      "regulatory_id": "131171",
      "orpha_substance_code": "ORPHA:391490",
      "details": [
        "SOLIRIS(Tradename                        - 16/03/2007)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuriaORPHA:2134 Atypical hemolytic uremic syndromeORPHA:71211 Neuromyelitis optica spectrum disorderORPHA:391490 Adult-onset myasthenia gravis",
        "SOLIRIS(Tradename                        - 16/03/2007)",
        "(Tradename                        - 16/03/2007)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuriaORPHA:2134 Atypical hemolytic uremic syndromeORPHA:71211 Neuromyelitis optica spectrum disorderORPHA:391490 Adult-onset myasthenia gravis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/82335?name=447&mode=orpha&region=&status=all",
          "text": "SOLIRIS",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2134",
          "text": "ORPHA:2134 Atypical hemolytic uremic syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/71211",
          "text": "ORPHA:71211 Neuromyelitis optica spectrum disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/391490",
          "text": "ORPHA:391490 Adult-onset myasthenia gravis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131171?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:71211 Neuromyelitis optica spectrum disorder\n                                \n\n\n\n\n                                    ORPHA:391490 Adult-onset myasthenia gravis\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Small molecule inhibitor of complement factor B",
      "substance_url": "/en/drug/substance/692559?name=447&mode=orpha&region=&status=all",
      "substance_id": "692559",
      "regulatory_url": "/en/drug/regulatory/692632?name=447&mode=orpha&region=",
      "regulatory_id": "692632",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Small molecule inhibitor of complement factor B(Medicinal product                        - 11/12/2024)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Small molecule inhibitor of complement factor B(Medicinal product                        - 11/12/2024)",
        "(Medicinal product                        - 11/12/2024)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/692559?name=447&mode=orpha&region=&status=all",
          "text": "Small molecule inhibitor of complement factor B",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/692632?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant, Humanized, Aglycosylated, Immunoglobulin G1 kappa Anti-Factor Bb Monoclonal Antibody",
      "substance_url": "/en/drug/substance/666398?name=447&mode=orpha&region=&status=all",
      "substance_id": "666398",
      "regulatory_url": "/en/drug/regulatory/666464?name=447&mode=orpha&region=",
      "regulatory_id": "666464",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Recombinant, Humanized, Aglycosylated, Immunoglobulin G1 kappa Anti-Factor Bb Monoclonal Antibody(Medicinal product                        - 20/12/2023)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Recombinant, Humanized, Aglycosylated, Immunoglobulin G1 kappa Anti-Factor Bb Monoclonal Antibody(Medicinal product                        - 20/12/2023)",
        "(Medicinal product                        - 20/12/2023)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/666398?name=447&mode=orpha&region=&status=all",
          "text": "Recombinant, Humanized, Aglycosylated, Immunoglobulin G1 kappa Anti-Factor Bb Monoclonal Antibody",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/666464?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant, Humanized, aglycosylated, IgG1 Kappa Anti-Properdin Monoclonal Antibody",
      "substance_url": "/en/drug/substance/634413?name=447&mode=orpha&region=&status=all",
      "substance_id": "634413",
      "regulatory_url": "/en/drug/regulatory/634414?name=447&mode=orpha&region=",
      "regulatory_id": "634414",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Recombinant, Humanized, aglycosylated, IgG1 Kappa Anti-Properdin Monoclonal Antibody(Medicinal product                        - 05/10/2022)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Recombinant, Humanized, aglycosylated, IgG1 Kappa Anti-Properdin Monoclonal Antibody(Medicinal product                        - 05/10/2022)",
        "(Medicinal product                        - 05/10/2022)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/634413?name=447&mode=orpha&region=&status=all",
          "text": "Recombinant, Humanized, aglycosylated, IgG1 Kappa Anti-Properdin Monoclonal Antibody",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/634414?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "OMS906",
      "substance_url": "/en/drug/substance/637255?name=447&mode=orpha&region=&status=all",
      "substance_id": "637255",
      "regulatory_url": "/en/drug/regulatory/637256?name=447&mode=orpha&region=",
      "regulatory_id": "637256",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "OMS906(Medicinal product                        - 28/07/2022)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "OMS906(Medicinal product                        - 28/07/2022)",
        "(Medicinal product                        - 28/07/2022)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/637255?name=447&mode=orpha&region=&status=all",
          "text": "OMS906",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/637256?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant IgG-fusion protein containing a humanized anti-C5 monoclonal antibody fused with a truncated human complement FH to the heavy chain C-terminus",
      "substance_url": "/en/drug/substance/637340?name=447&mode=orpha&region=&status=all",
      "substance_id": "637340",
      "regulatory_url": "/en/drug/regulatory/637341?name=447&mode=orpha&region=",
      "regulatory_id": "637341",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Recombinant IgG-fusion protein containing a humanized anti-C5 monoclonal antibody fused with a truncated human complement FH to the heavy chain C-terminus(Medicinal product                        - 20/07/2022)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Recombinant IgG-fusion protein containing a humanized anti-C5 monoclonal antibody fused with a truncated human complement FH to the heavy chain C-terminus(Medicinal product                        - 20/07/2022)",
        "(Medicinal product                        - 20/07/2022)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/637340?name=447&mode=orpha&region=&status=all",
          "text": "Recombinant IgG-fusion protein containing a humanized anti-C5 monoclonal antibody fused with a truncated human complement FH to the heavy chain C-terminus",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/637341?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Cemdisiran",
      "substance_url": "/en/drug/substance/504663?name=447&mode=orpha&region=&status=all",
      "substance_id": "504663",
      "regulatory_url": "/en/drug/regulatory/634568?name=447&mode=orpha&region=",
      "regulatory_id": "634568",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Cemdisiran(Medicinal product                        - 10/02/2022)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Cemdisiran(Medicinal product                        - 10/02/2022)",
        "(Medicinal product                        - 10/02/2022)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/504663?name=447&mode=orpha&region=&status=all",
          "text": "Cemdisiran",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/634568?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "BCX9930",
      "substance_url": "/en/drug/substance/622067?name=447&mode=orpha&region=&status=all",
      "substance_id": "622067",
      "regulatory_url": "/en/drug/regulatory/622068?name=447&mode=orpha&region=",
      "regulatory_id": "622068",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "BCX9930(Medicinal product                        - 28/08/2020)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "BCX9930(Medicinal product                        - 28/08/2020)",
        "(Medicinal product                        - 28/08/2020)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/622067?name=447&mode=orpha&region=&status=all",
          "text": "BCX9930",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/622068?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Danicopan",
      "substance_url": "/en/drug/substance/500656?name=447&mode=orpha&region=&status=all",
      "substance_id": "500656",
      "regulatory_url": "/en/drug/regulatory/500662?name=447&mode=orpha&region=",
      "regulatory_id": "500662",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Danicopan(Medicinal product                        - 02/11/2017)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Danicopan(Medicinal product                        - 02/11/2017)",
        "(Medicinal product                        - 02/11/2017)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/500656?name=447&mode=orpha&region=&status=all",
          "text": "Danicopan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/500662?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Ravulizumab",
      "substance_url": "/en/drug/substance/479982?name=447&mode=orpha&region=&status=all",
      "substance_id": "479982",
      "regulatory_url": "/en/drug/regulatory/479984?name=447&mode=orpha&region=",
      "regulatory_id": "479984",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Ravulizumab(Medicinal product                        - 04/01/2017)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Ravulizumab(Medicinal product                        - 04/01/2017)",
        "(Medicinal product                        - 04/01/2017)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/479982?name=447&mode=orpha&region=&status=all",
          "text": "Ravulizumab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/479984?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Nomacopan",
      "substance_url": "/en/drug/substance/590018?name=447&mode=orpha&region=&status=all",
      "substance_id": "590018",
      "regulatory_url": "/en/drug/regulatory/480232?name=447&mode=orpha&region=",
      "regulatory_id": "480232",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Nomacopan(Medicinal product                        - 08/09/2016)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Nomacopan(Medicinal product                        - 08/09/2016)",
        "(Medicinal product                        - 08/09/2016)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/590018?name=447&mode=orpha&region=&status=all",
          "text": "Nomacopan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480232?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)",
      "substance_url": "/en/drug/substance/406538?name=447&mode=orpha&region=&status=all",
      "substance_id": "406538",
      "regulatory_url": "/en/drug/regulatory/412689?name=447&mode=orpha&region=",
      "regulatory_id": "412689",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)(Medicinal product                        - 09/10/2014)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)(Medicinal product                        - 09/10/2014)",
        "(Medicinal product                        - 09/10/2014)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/406538?name=447&mode=orpha&region=&status=all",
          "text": "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/412689?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "PEGylated peptide inhibitor of complement C3",
      "substance_url": "/en/drug/substance/489701?name=447&mode=orpha&region=&status=all",
      "substance_id": "489701",
      "regulatory_url": "/en/drug/regulatory/570664?name=447&mode=orpha&region=",
      "regulatory_id": "570664",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "PEGylated peptide inhibitor of complement C3(Medicinal product                        - 20/04/2014)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "PEGylated peptide inhibitor of complement C3(Medicinal product                        - 20/04/2014)",
        "(Medicinal product                        - 20/04/2014)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/489701?name=447&mode=orpha&region=&status=all",
          "text": "PEGylated peptide inhibitor of complement C3",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/570664?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Eculizumab",
      "substance_url": "/en/drug/substance/82334?name=447&mode=orpha&region=&status=all",
      "substance_id": "82334",
      "regulatory_url": "/en/drug/regulatory/132066?name=447&mode=orpha&region=",
      "regulatory_id": "132066",
      "orpha_substance_code": "ORPHA:447",
      "details": [
        "Eculizumab(Medicinal product                        - 20/08/2003)Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "Eculizumab(Medicinal product                        - 20/08/2003)",
        "(Medicinal product                        - 20/08/2003)",
        "Disease(s) concernedORPHA:447 Paroxysmal nocturnal hemoglobinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/82334?name=447&mode=orpha&region=&status=all",
          "text": "Eculizumab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/447",
          "text": "ORPHA:447 Paroxysmal nocturnal hemoglobinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/132066?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PLERIXAFOR ACCORD",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/642317?name=447&mode=orpha&region=",
      "regulatory_id": "642317",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "PLERIXAFOR ACCORD(Tradename                        - 16/12/2022)Disease(s) concernedORPHA:29073 Multiple myelomaORPHA:223735 LymphomaORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "PLERIXAFOR ACCORD(Tradename                        - 16/12/2022)",
        "(Tradename                        - 16/12/2022)",
        "Disease(s) concernedORPHA:29073 Multiple myelomaORPHA:223735 LymphomaORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/642316?name=447&mode=orpha&region=&status=all",
          "text": "PLERIXAFOR ACCORD",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/29073",
          "text": "ORPHA:29073 Multiple myeloma",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/223735",
          "text": "ORPHA:223735 Lymphoma",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/642317?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Thiotepa Riemser",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/610636?name=447&mode=orpha&region=",
      "regulatory_id": "610636",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Thiotepa Riemser(Tradename                        - 26/03/2021)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Thiotepa Riemser(Tradename                        - 26/03/2021)",
        "(Tradename                        - 26/03/2021)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/610616?name=447&mode=orpha&region=&status=all",
          "text": "Thiotepa Riemser",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/610636?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "motixafortide",
      "substance_url": "/en/drug/substance/588874?name=447&mode=orpha&region=&status=all",
      "substance_id": "588874",
      "regulatory_url": "/en/drug/regulatory/661036?name=447&mode=orpha&region=",
      "regulatory_id": "661036",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "motixafortide(Medicinal product                        - 12/01/2024)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "motixafortide(Medicinal product                        - 12/01/2024)",
        "(Medicinal product                        - 12/01/2024)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/588874?name=447&mode=orpha&region=&status=all",
          "text": "motixafortide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661036?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate",
      "substance_url": "/en/drug/substance/589233?name=447&mode=orpha&region=&status=all",
      "substance_id": "589233",
      "regulatory_url": "/en/drug/regulatory/589234?name=447&mode=orpha&region=",
      "regulatory_id": "589234",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate(Medicinal product                        - 20/04/2020)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate(Medicinal product                        - 20/04/2020)",
        "(Medicinal product                        - 20/04/2020)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589233?name=447&mode=orpha&region=&status=all",
          "text": "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589234?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus",
      "substance_url": "/en/drug/substance/589056?name=447&mode=orpha&region=&status=all",
      "substance_id": "589056",
      "regulatory_url": "/en/drug/regulatory/589057?name=447&mode=orpha&region=",
      "regulatory_id": "589057",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus(Medicinal product                        - 24/03/2020)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus(Medicinal product                        - 24/03/2020)",
        "(Medicinal product                        - 24/03/2020)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589056?name=447&mode=orpha&region=&status=all",
          "text": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589057?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Cord blood derived T regulatory cells",
      "substance_url": "/en/drug/substance/699871?name=447&mode=orpha&region=&status=all",
      "substance_id": "699871",
      "regulatory_url": "/en/drug/regulatory/700242?name=447&mode=orpha&region=",
      "regulatory_id": "700242",
      "orpha_substance_code": "ORPHA:182040",
      "details": [
        "Cord blood derived T regulatory cells(Medicinal product                        - 04/04/2025)Disease(s) concernedORPHA:182040 Rare aplastic anemia",
        "Cord blood derived T regulatory cells(Medicinal product                        - 04/04/2025)",
        "(Medicinal product                        - 04/04/2025)",
        "Disease(s) concernedORPHA:182040 Rare aplastic anemia",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/699871?name=447&mode=orpha&region=&status=all",
          "text": "Cord blood derived T regulatory cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182040",
          "text": "ORPHA:182040 Rare aplastic anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/700242?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=447&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=447&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=447&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Besilesomab",
      "substance_url": "/en/drug/substance/571152?name=447&mode=orpha&region=&status=all",
      "substance_id": "571152",
      "regulatory_url": "/en/drug/regulatory/641081?name=447&mode=orpha&region=",
      "regulatory_id": "641081",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Besilesomab(Medicinal product                        - 28/03/2022)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Besilesomab(Medicinal product                        - 28/03/2022)",
        "(Medicinal product                        - 28/03/2022)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/571152?name=447&mode=orpha&region=&status=all",
          "text": "Besilesomab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641081?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Besilesomab",
      "substance_url": "/en/drug/substance/571152?name=447&mode=orpha&region=&status=all",
      "substance_id": "571152",
      "regulatory_url": "/en/drug/regulatory/641075?name=447&mode=orpha&region=",
      "regulatory_id": "641075",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Besilesomab(Medicinal product                        - 28/03/2022)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Besilesomab(Medicinal product                        - 28/03/2022)",
        "(Medicinal product                        - 28/03/2022)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/571152?name=447&mode=orpha&region=&status=all",
          "text": "Besilesomab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641075?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=447&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=447&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=447&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=447&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=447&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=447&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=447&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:25.435991",
  "run_number": 1,
  "total_drugs_found": 50,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Paroxysmal+nocturnal+hemoglobinuria&orphaCode=447&name=447&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Paroxysmal nocturnal hemoglobinuria",
    "orphaCode": "447",
    "name": "447",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}